The isolation, total synthesis and structure elucidation of chlorofusin, a natural product inhibitor of the p53-MDM2 protein-protein interaction

被引:36
|
作者
Clark, Ryan C. [2 ]
Lee, Sang Yeul [2 ]
Searcey, Mark [1 ]
Boger, Dale L. [2 ]
机构
[1] Univ E Anglia, Sch Chem Sci & Pharm, Norwich NR4 7TJ, Norfolk, England
[2] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
基金
美国国家卫生研究院;
关键词
CYCLIC PEPTIDE PORTION; SOLID-PHASE SYNTHESIS; ABSOLUTE-CONFIGURATION; P53/MDM2; INTERACTION; CANCER-THERAPY; MDM2; P53; AZAPHILONES; CHEMISTRY; FUNGI;
D O I
10.1039/b821676b
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibitors of key protein-protein interactions are emerging as exciting therapeutic targets for the treatment of cancer. One such interaction between MDM2 (HDM2) and p53, that silences the tumour suppression activities of p53, was found to be inhibited by the recently isolated natural product chlorofusin. Synthetic studies on this complex natural product summarized herein have served to reassign its chromophore relative stereochemistry, assign its absolute stereochemistry, and provided access to a series of key analogues and partial structures for biological evaluation.
引用
收藏
页码:465 / 477
页数:13
相关论文
共 50 条
  • [31] Identification of substituted isoindolinones as potent inhibitors of the MDM2-p53 protein-protein interaction
    Watson, Anna
    Liu, Junfeng
    Armstrong, Elizabeth
    Blackburn, Timothy
    Endicott, Jane A.
    Golding, Bernard T.
    Griffin, Roger J.
    Lu, Xiaohong
    Newell, David R.
    Noble, Martin E. M.
    Riedinger, Christiane
    Lunec, John
    Hardcastle, Ian R.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [32] MDM2-p53 protein-protein interaction inhibitors: A-ring substituted isoindolinones
    Watson, Anna F.
    Liu, Junfeng
    Bennaceur, Karim
    Drummond, Catherine J.
    Endicott, Jane A.
    Golding, Bernard T.
    Griffin, Roger J.
    Haggerty, Karen
    Lu, Xiaohong
    McDonnell, James M.
    Newell, David R.
    Noble, Martin E. M.
    Revill, Charlotte H.
    Riedinger, Christiane
    Xu, Qing
    Zhao, Yan
    Lunec, John
    Hardcastle, Ian R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (19) : 5916 - 5919
  • [33] Design and synthesis of dual inhibitors of the MDM2-p53 and MDMX-p53 protein-protein interactions
    Adhikari, Santosh
    Cano, Celine
    Golding, Bernard
    Hardcastle, Ian
    Harnor, Suzannah
    Jennings, Claire
    Lunec, John
    Myers, Stephanie
    Newell, D.
    Reeks, Judith
    Shouksmith, Andrew
    Tudhope, Sue
    Wedge, Steve
    Willmore, Elaine
    Wittner, Anita
    Zhao, Yan
    Griffin, Roger
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [34] Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function
    Chen, D.
    Zhang, Z.
    Li, M.
    Wang, W.
    Li, Y.
    Rayburn, E. R.
    Hill, D. L.
    Wang, H.
    Zhang, R.
    ONCOGENE, 2007, 26 (35) : 5029 - 5037
  • [35] Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein-protein inhibitors
    Beck, Hilary P.
    DeGraffenreid, Michael
    Fox, Brian
    Allen, John G.
    Rew, Yosup
    Schneider, Stephen
    Saiki, Anne Y.
    Yu, Dongyin
    Oliner, Jonathan D.
    Salyers, Kevin
    Ye, Qiuping
    Olson, Steven
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (09) : 2752 - 2755
  • [36] Mathematical Simulation of p53-Mdm2 Protein Biological System Regulation
    Voropaeva, O. F.
    Shokin, Yu. I.
    Nepomnyashchikh, L. M.
    Senchukova, S. R.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 157 (04) : 535 - 538
  • [37] NEW PLAYERS IN CANCER THERAPEUTICS: FOCUS ON INHIBITORS OF MDM2-P53 PROTEIN-PROTEIN INTERACTION
    Capdevila, J.
    Cervantes, A.
    Tabernero, J.
    DRUGS OF THE FUTURE, 2012, 37 (04) : 273 - 281
  • [38] Development of a potent class of small molecule inhibitors of the MDM2-p53 protein-protein interaction
    Fazal, Lynsey
    Ahn, Maria
    Bevan, Luke
    Buck, Ildiko
    Castro, Juan
    Chessari, Gianni
    Cons, Ben
    Hearn, Keisha
    Howard, Steven
    Johnson, Chris
    Reeks, Judith
    Tamanini, Emiliano
    Thompson, Neil
    Walton, Hugh
    Williams, Pamela
    Bawn, Ruth H.
    Blackburn, Tim J.
    Cano, Celine
    Cully, Sarah J.
    Golding, Bernard
    Griffin, Roger
    Haggerty, Karen
    Hardcastle, Ian
    Newell, Herbie
    Noble, Martin
    Thomas, Huw
    Willmore, Elaine
    Zhao, Yan
    Wedge, Steve
    CANCER RESEARCH, 2018, 78 (13)
  • [39] An Application of Fit Quality to Screen MDM2/p53 Protein-Protein Interaction Inhibitors
    Xue, Xin
    Bao, Gang
    Zhang, Hai-Qing
    Zhao, Ning-Yi
    Sun, Yuan
    Zhang, Yue
    Wang, Xiao-Long
    MOLECULES, 2018, 23 (12):
  • [40] MEDI 147-Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction
    Watson, Anna F.
    Golding, Bernard T.
    Griffin, Roger J.
    Hutton, Claire
    Liu, Junfeng
    Lu, Xiaohong
    Lunec, John
    Newell, David R.
    Valeur, Eric
    Hardcastle, Ian R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236